admin

$158,000 price tag for new ALS drug reignites anger at Big Pharma

A new ALS drug treatment is reawakening frustration with Big Pharma after its drugmaker priced it at $158,000 annually, leading to exorbitant insurance processes to access it. Relyvrio, a drug produced by Amylyx Pharmaceutical, has been found to slow the progress of Amyotrophic Lateral Sclerosis, a disease that typically proves …

Read More »